The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio.
European urology. 2020 Dec 29 [Epub]
Hendrik Van Poppel, Renée Hogenhout, Peter Albers, Roderick C N van den Bergh, Jelle O Barentsz, Monique J Roobol
Department of Development and Regeneration, University Hospital KU Leuven, Leuven, Belgium. Electronic address: ., Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Department of Urology, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany; Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center, Heidelberg, Germany., Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands., Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/33384200
Go Beyond the Abstract and Read a Commentary by the Authors